The Role and Application of the PI3K/Akt Signaling Pathway in Breast Cancer with Endocrine Therapy Resistance

LIN Yang, ZHANG Bin

Welcome to Labeled Immunoassays and Clinical Medicine website!
Labeled Immunoassays and Clinical Medicine ›› 2015, Vol. 22 ›› Issue (12) : 1287. DOI: 10.11748/bjmy.issn.1006-1703.2015.12.028

The Role and Application of the PI3K/Akt Signaling Pathway in Breast Cancer with Endocrine Therapy Resistance

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2015, 22(12): 1287 https://doi.org/10.11748/bjmy.issn.1006-1703.2015.12.028

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-1
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　Fax: 010-68533122　E-mail: bjmy@circ.com.cn
Powered by Beijing Magtech Co., Ltd.

/

〈 〉